文献速递糖尿病

人胰岛细胞分化模型的差异基因表达模式及其与2型糖尿病易感性的关系

Patterns of differential gene expression in a cellular model of human islet development, and relationship to type 2 diabetes predisposition.
PubMed 文献 · Diabetologia · 2018-04-19

研究对来自三名独立供体的人诱导多能干细胞(iPSC)系在体外胰岛分化过程的基线及七个阶段进行全转录组RNA测序,鉴定出9409个差异表达基因,并发现超过70%的2型糖尿病GWAS可信区间内基因在胰岛发育过程中出现峰值差异表达,提示2型糖尿病遗传易感性部分通过调控胰岛发育介导。

要点

  • 体外胰岛分化各阶段共鉴定出9409个差异表达基因,包含众多已知胰岛发育标志物。
  • 超过70%的2型糖尿病GWAS可信区间内基因在胰岛发育过程中出现峰值差异表达。
  • 效应最大的2型糖尿病GWAS位点(含TCF7L2)在后前肠阶段差异表达基因中富集(q=0.002)。

核心结论

  • 本研究刻画了人胰岛分化过程中的RNA表达谱,识别了分化过程的潜在转录调控因子,并提示2型糖尿病的遗传易感性部分通过调控胰岛发育介导。

研究设计与样本

  • 对来自三名独立供体的人iPSC系在基线及体外胰岛分化七个后续阶段进行全转录组RNA测序。
  • 差异表达基因定义为q < 0.01且log2倍数变化(FC)> 1,并归属至其上调最显著的阶段。

主要发现

  • 所有阶段共鉴定出9409个差异表达基因,包括许多已知胰岛发育标志物。
  • 将差异表达数据与转录因子基序信息整合,提示REST对胰岛发育的潜在贡献。
  • 超过70%的2型糖尿病相关可信区间内基因在胰岛发育过程中显示峰值差异表达。
  • 效应最大的2型糖尿病GWAS位点(包括TCF7L2;log2FC = 1.2;q = 8.5 × 10-10)在后前肠阶段差异表达基因中显著富集(q = 0.002),由基因集富集分析计算。
  • 在体外分化最终β样细胞阶段差异表达的基因,对2型糖尿病GWAS位点可信区间内基因显著富集(超几何检验,置换p值 < 0.05)。

关键数值与推荐

  • 差异表达基因阈值:q < 0.01且log2倍数变化(FC)> 1。
  • TCF7L2:log2FC = 1.2;q = 8.5 × 10-10。
  • 后前肠阶段基因集富集分析:q = 0.002。
  • 最终β样细胞阶段富集分析:超几何检验,置换p值 < 0.05。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Most type 2 diabetes-associated genetic variants identified via genome-wide association studies (GWASs) appear to act via the pancreatic islet. Observed defects in insulin secretion could result from an impact of these variants on islet development and/or the function of mature islets. Most functional studies have focused on the latter, given limitations regarding access to human fetal islet tissue. Capitalising upon advances in in vitro differentiation, we characterised the transcriptomes of human induced pluripotent stem cell (iPSC) lines differentiated along the pancreatic endocrine lineage, and explored the contribution of altered islet development to the pathogenesis of type 2 diabetes. METHODS: We performed whole-transcriptome RNA sequencing of human iPSC lines from three independent donors, at baseline and at seven subsequent stages during in vitro islet differentiation. Differentially expressed genes (q < 0.01, log2 fold change [FC] > 1) were assigned to the stages at which they were most markedly upregulated. We used these data to characterise upstream transcription factors directing different stages of development, and to explore the relationship between RNA expression profiles and genes mapping to type 2 diabetes GWAS signals. RESULTS: We identified 9409 differentially expressed genes across all stages, including many known markers of islet development. Integration of differential expression data with information on transcription factor motifs highlighted the potential contribution of REST to islet development. Over 70% of genes mapping within type 2 diabetes-associated credible intervals showed peak differential expression during islet development, and type 2 diabetes GWAS loci of largest effect (including TCF7L2; log2FC = 1.2; q = 8.5 × 10-10) were notably enriched in genes differentially expressed at the posterior foregut stage (q = 0.002), as calculated by gene set enrichment analyses. In a complementary analysis of enrichment, genes differentially expressed in the final, beta-like cell stage of in vitro differentiation were significantly enriched (hypergeometric test, permuted p value <0.05) for genes within the credible intervals of type 2 diabetes GWAS loci. CONCLUSIONS/INTERPRETATION: The present study characterises RNA expression profiles during human islet differentiation, identifies potential transcriptional regulators of the differentiation process, and suggests that the inherited predisposition to type 2 diabetes is partly mediated through modulation of islet development. DATA AVAILABILITY: Sequence data for this study has been deposited at the European Genome-phenome Archive (EGA), under accession number EGAS00001002721.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Perez-Alcantara M, Honoré C, Wesolowska-Andersen A, et al. Patterns of differential gene expression in a cellular model of human islet development, and relationship to type 2 diabetes predisposition. Diabetologia. 2018. PMID: 29675560. doi:10.1007/s00125-018-4612-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。